Patents by Inventor Agnieszka MASZEWSKA

Agnieszka MASZEWSKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050498
    Abstract: The formation method was revealed of a bacteriophage synergistic composition intended to prevent and combat infections of livestock, including but not limited to poultry, with pathogenic bacteria strains sensitive to the phages.
    Type: Application
    Filed: June 28, 2021
    Publication date: February 15, 2024
    Applicant: Proteon Pharmaceuticals S.A.
    Inventors: Jaroslaw DASTYCH, Ewelina A. WÓJCIK, Agnieszka MASZEWSKA, Malgorzata STANCZYK, Anna PEKALA, Edyta SMIGIELSKA, Ewelina WOJDA, Joanna KAZIMIERCZAK, Arkadiusz GUZI?SKI, Justyna ANDRYSIAK, Paulina WIGNER
  • Patent number: 10435671
    Abstract: The invention covers new bacteriophage strains specific against bacteria belonging to the species Proteus mirabilis, deposited with the Polish Collection of Microorganisms (PCM) under the access numbers: F/00084 (72APm5211), F/00085 (39APmC32), F/00086 (65APm2833), for use for use in the prophylaxis and therapy. In accordance with the invention the above mentioned bacteriophage strains, in form of complete particles of the single bacteriophage strain, in form of bacteriophage lysates, optionally in form of purified bacteriophage proteins, in particular lytic enzymes that degrade the bacterial cell wall and enzymes that decompose bacterial extracellular polysaccharides, are intended for use in therapy as anti-bacterial agents, in particular against bacteria of the species Proteus mirabilis, especially the drug- and multidrug-resistant strains of the species, advantageously in urinary tract infections.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: October 8, 2019
    Assignee: UNIWERSYTET LODZKI
    Inventors: Agnieszka Maszewska, Antoni Rozalski
  • Publication number: 20190032022
    Abstract: The invention covers new bacteriophage strains specific against bacteria belonging to the species Proteus mirabilis, deposited with the Polish Collection of Microorganisms (PCM) under the access numbers: F/00084 (72APm5211), F/00085 (39APmC32), F/00086 (65APm2833), for use for use in the prophylaxis and therapy. In accordance with the invention the above mentioned bacteriophage strains, in form of complete particles of the single bacteriophage strain, in form of bacteriophage lysates, optionally in form of purified bacteriophage proteins, in particular lytic enzymes that degrade the bacterial cell wall and enzymes that decompose bacterial extracellular polysaccharides, are intended for use in therapy as anti-bacterial agents, in particular against bacteria of the species Proteus mirabilis, especially the drug- and multidrug-resistant strains of the species, advantageously in urinary tract infections.
    Type: Application
    Filed: July 7, 2016
    Publication date: January 31, 2019
    Inventors: Agnieszka MASZEWSKA, Antoni ROZALSKI